NASDAQ: GYRE
Gyre Therapeutics Inc Earnings Dates, Reports, Calls

Gyre Therapeutics earnings were -$18.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest GYRE earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$11.7M, up 34.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GYRE reported annual earnings of $5.0M, with -58.4% growth. The next GYRE earnings date is Nov 6, 2026.

GYRE earnings history

Current Revenue
$119.4M
Current Earnings
-$18.5M
Current Profit Margin
-15.5%

GYRE Return on Equity

Current Company
-19.8%
Current Industry
-13.6%
Current Market
31%
GYRE's Return on Equity (-17.7%)... subscribe to Premium to read more.
High Return on Equity Performance

GYRE Return on Assets

Current Company
-10%
Current Industry
-10.2%
GYRE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when GYRE announces earnings.

GYRE Return on Capital Employed

Current Company
-8.18%
Current Industry
-6.7%
GYRE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GYRE vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
GYRE-$9.68M-$18.47MN/A-$0.20
IVA-$155.78M-$411.79MN/A-$2.21
PHAR$31.74M$10.57M-22.56%$0.16
ANNX-$198.86M-$202.67MN/A-$1.14
FDMT-$171.05M-$179.18MN/A-$2.63

GYRE earnings dates

Next earnings date
Nov 6, 2026

Gyre Therapeutics Earnings Reports & History FAQ

What were Gyre Therapeutics's earnings last quarter?

On GYRE's earnings call on Aug 10, 2026, Gyre Therapeutics (NASDAQ: GYRE) reported Q2 2026 earnings per share (EPS) of -$0.12, up 500% year over year. Total GYRE earnings for the quarter were -$11.66 million. In the same quarter last year, Gyre Therapeutics's earnings per share (EPS) was -$0.02.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.

When does Gyre Therapeutics report earnings?

The next GYRE earnings date is Nov 6, 2026. Add GYRE to your watchlist to be reminded of Gyre Therapeutics's next earnings date.

Is Gyre Therapeutics profitable or losing money?

As of the last Gyre Therapeutics earnings report, Gyre Therapeutics is currently losing money. Gyre Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$17.41 million, a 502.89% decrease year over year.

What was GYRE's earnings growth in the past year?

As of Gyre Therapeutics's earnings date in Aug 10, 2026, Gyre Therapeutics's earnings has grown year over year. GYRE earnings in the past year totalled -$18.47 million.

What are Gyre Therapeutics's earnings expectations?

The current EPS estimate for Gyre Therapeutics's earnings report in Nov 6, 2026 is -$0.14.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.